SG10201900041VA - Meningococcus vaccines - Google Patents

Meningococcus vaccines

Info

Publication number
SG10201900041VA
SG10201900041VA SG10201900041VA SG10201900041VA SG10201900041VA SG 10201900041V A SG10201900041V A SG 10201900041VA SG 10201900041V A SG10201900041V A SG 10201900041VA SG 10201900041V A SG10201900041V A SG 10201900041VA SG 10201900041V A SG10201900041V A SG 10201900041VA
Authority
SG
Singapore
Prior art keywords
vaccines
meningococcus
meningococcus vaccines
fhbp
diversity
Prior art date
Application number
SG10201900041VA
Other languages
English (en)
Inventor
Alessia Biolchi
Brunella Brunelli
Marzia Monica Giuliani
Vega Masignani
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of SG10201900041VA publication Critical patent/SG10201900041VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
SG10201900041VA 2014-07-17 2015-07-16 Meningococcus vaccines SG10201900041VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14177563 2014-07-17

Publications (1)

Publication Number Publication Date
SG10201900041VA true SG10201900041VA (en) 2019-02-27

Family

ID=51178811

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201900041VA SG10201900041VA (en) 2014-07-17 2015-07-16 Meningococcus vaccines
SG11201610946YA SG11201610946YA (en) 2014-07-17 2015-07-16 Meningococcus vaccines

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201610946YA SG11201610946YA (en) 2014-07-17 2015-07-16 Meningococcus vaccines

Country Status (15)

Country Link
US (3) US11707513B2 (https=)
EP (1) EP3169358A1 (https=)
JP (2) JP6687597B2 (https=)
KR (2) KR20230012100A (https=)
CN (2) CN106659776A (https=)
AR (2) AR101225A1 (https=)
AU (2) AU2015289193A1 (https=)
BE (1) BE1022878B1 (https=)
BR (1) BR112017000519A2 (https=)
CA (1) CA2954729C (https=)
EA (1) EA038940B1 (https=)
IL (1) IL249823B (https=)
MX (1) MX2017000775A (https=)
SG (2) SG10201900041VA (https=)
WO (1) WO2016008961A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
JP6687597B2 (ja) 2014-07-17 2020-04-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 髄膜炎菌ワクチン
EP3169357B1 (en) 2014-07-17 2018-11-07 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
US10975131B2 (en) * 2015-10-27 2021-04-13 University Of Massachusetts Factor H-Fc immunotheraphy
CN107151270B (zh) * 2017-03-22 2018-07-31 武汉博沃生物科技有限公司 重组ΔfHbp-NadA融合蛋白载体及其制备方法和应用
CN108939061A (zh) * 2018-08-03 2018-12-07 北京智飞绿竹生物制药有限公司 一种多组分b群脑膜炎球菌疫苗及其制备方法
EP3607967A1 (en) * 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
US11014736B2 (en) 2019-04-18 2021-05-25 Altria Client Services Llc Sliding packs with flip top hinged lids
CN110804101A (zh) * 2019-11-08 2020-02-18 苏州微超生物科技有限公司 B群脑膜炎球菌相关融合蛋白、疫苗及其制备方法与应用
MX2022006299A (es) * 2019-11-25 2023-01-19 Univ Griffith Proteína inmunogénica contra una infección gonocócica.
GB202115151D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Methods
CN119792505A (zh) * 2023-10-10 2025-04-11 康希诺生物股份公司 一种抗脑膜炎球菌的免疫组合物及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747137B1 (en) 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US6551795B1 (en) 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
TR201802933T4 (tr) 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
GB201120634D0 (en) 2011-11-30 2012-01-11 Univ Sheffield Adjuvant polypeptide
AU2013276083B2 (en) * 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
GB201215005D0 (en) 2012-08-23 2012-10-10 Isis Innovation Stabilised meningitis vaccine
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
EP2916512B1 (en) 2014-03-07 2016-08-24 Mitsubishi Electric R&D Centre Europe B.V. Method for classifying a TCP connection carrying HTTP traffic as a trusted or an untrusted TCP connection
JP6687597B2 (ja) 2014-07-17 2020-04-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 髄膜炎菌ワクチン
EP3169357B1 (en) 2014-07-17 2018-11-07 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
CA3103741A1 (en) 2018-06-21 2019-12-26 Basf Se 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers

Also Published As

Publication number Publication date
US20230414736A1 (en) 2023-12-28
CA2954729A1 (en) 2016-01-21
AU2019201131A1 (en) 2019-03-07
BE1022878A1 (fr) 2016-09-30
EA038940B1 (ru) 2021-11-12
AR101225A1 (es) 2016-11-30
CA2954729C (en) 2023-08-22
CN106659776A (zh) 2017-05-10
JP2017522319A (ja) 2017-08-10
CN113827712A (zh) 2021-12-24
US20180214531A1 (en) 2018-08-02
AU2019201131C1 (en) 2021-03-18
IL249823B (en) 2022-07-01
AR130778A2 (es) 2025-01-15
KR20230012100A (ko) 2023-01-25
IL249823A0 (en) 2017-03-30
WO2016008961A1 (en) 2016-01-21
US20260097107A1 (en) 2026-04-09
BE1022878B1 (fr) 2016-09-30
US12485164B2 (en) 2025-12-02
EA201692554A1 (ru) 2017-07-31
EP3169358A1 (en) 2017-05-24
JP2020117523A (ja) 2020-08-06
AU2015289193A1 (en) 2017-02-02
AU2019201131B2 (en) 2020-08-27
MX2017000775A (es) 2017-05-04
JP6687597B2 (ja) 2020-04-22
KR20170029615A (ko) 2017-03-15
US11707513B2 (en) 2023-07-25
BR112017000519A2 (pt) 2017-11-21
SG11201610946YA (en) 2017-01-27
KR102626831B1 (ko) 2024-01-22
JP7074793B2 (ja) 2022-05-24

Similar Documents

Publication Publication Date Title
SG10201900041VA (en) Meningococcus vaccines
ZA202004557B (en) Modulatory polynucleotides
PH12019500627A1 (en) Affinity-oligonucleotide conjugates and uses thereof
IL267346B1 (en) Violent attenuated bacteria based on protein delivery
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2019007020A (es) Anticuerpos il-11.
SG10201803042PA (en) Anti-tim-3 antibodies
MX2019007021A (es) Anticuerpos il-11ra.
MY187540A (en) Compounds active towards bromodomains
EP3303382A4 (en) Compositions and methods for treating patients with rtk mutant cells
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
TW201613966A (en) SynTac polypeptides and uses thereof
MX384192B (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
MY191581A (en) Anti-pd-1 antibodies
EP3604535A3 (en) Methods and compositions for weed control
MY191539A (en) Streptococcal vaccine
EP4650000A3 (en) High concentration formulation
MX2021005373A (es) Variantes de proteinas de union al factor h y metodos de uso de estas.
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX2016009056A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
NZ721832A (en) Solid forms of tenofovir
WO2016077580A3 (en) Compositions and methods for treating melanoma